Strategic Advisory Partners LLC Takes Position in iShares Biotechnology ETF $IBB

Posted by Alphonse Anthony on Jun 20th, 2026

Strategic Advisory Partners LLC acquired a new position in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) in the 4th quarter, HoldingsChannel reports. The institutional investor acquired 29,235 shares of the financial services provider’s stock, valued at approximately $4,934,000. iShares Biotechnology ETF accounts for about 4.1% of Strategic Advisory Partners LLC’s investment portfolio, making the stock its 6th largest holding.

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. Basepoint Wealth LLC purchased a new position in iShares Biotechnology ETF in the fourth quarter valued at $26,000. Cary Street Partners Financial LLC purchased a new stake in iShares Biotechnology ETF during the 4th quarter worth about $29,000. Darwin Wealth Management LLC purchased a new stake in iShares Biotechnology ETF during the 2nd quarter worth about $25,000. Caitlin John LLC acquired a new position in shares of iShares Biotechnology ETF during the 4th quarter worth about $34,000. Finally, Cornerstone Planning Group LLC acquired a new position in shares of iShares Biotechnology ETF during the 4th quarter worth about $35,000. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

IBB opened at $173.64 on Friday. iShares Biotechnology ETF has a one year low of $123.61 and a one year high of $179.64. The business’s 50-day simple moving average is $170.61 and its 200-day simple moving average is $170.66.

iShares Biotechnology ETF Cuts Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, June 18th. Investors of record on Monday, June 15th were paid a dividend of $0.0238 per share. The ex-dividend date was Monday, June 15th. This represents a $0.10 annualized dividend and a yield of 0.1%.

iShares Biotechnology ETF Profile

(Free Report)

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.